| CAS ID: | 154598-52-4 |
| Molecular Formula: | C14H9ClF3NO2 |
| Molecular Weight: | 315.7 g/mol |
| Monoisotopic Mass: | 315.0274 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | SUSTIVA 600 | SUSTIVA | Efavirenz |
| Analysis: | Drug repositioning mechanism analysis |
Trial Record 1
| ClinicalTrial ID | NCT02499562 | Disease | Liver fibrosis |
| Phase | Phase 2 | Status | Unknown |
| First Received | July 16, 2015 | Last Verified | July 16, 2015 |
| Sponsor | Shanghai Genomics, Inc. | ||
Trial Record 2
| ClinicalTrial ID | NCT01529749 | Disease | Liver fibrosis |
| Phase | Phase 4 | Status | Completed |
| First Received | February 9, 2012 | Last Verified | February 19, 2016 |
| Sponsor | Felipe Garcia | ||
Trial Record 3
| ClinicalTrial ID | NCT00023218 | Disease | Liver fibrosis |
| Phase | Not Applicable | Status | Withdrawn |
| First Received | August 31, 2001 | Last Verified | March 9, 2015 |
| Sponsor | National Institute of Allergy and Infectious Diseases (NIAID) | ||
Trial Record 4
| ClinicalTrial ID | NCT01908660 | Disease | Liver fibrosis |
| Phase | Status | Completed | |
| First Received | July 26, 2013 | Last Verified | November 11, 2015 |
| Sponsor | Valme University Hospital | ||
Trial Record 5
| ClinicalTrial ID | NCT02750059 | Disease | Cystic fibrosis |
| Phase | Phase 2 | Status | Active, not recruiting |
| First Received | April 25, 2016 | Last Verified | April 18, 2018 |
| Sponsor | South East Asia Research Collaboration with Hawaii | ||
| PubChem: | 64139 |
| ChEMBL: | CHEMBL223228 |